Select Page

Latest News

May 12, 2022
Rapid Dose Therapeutics Provides Shareholder Update Regarding Vaccine Collaboration Agreement with Oakland Health Limited in the United Kingdom

April 26, 2022
Rapid Dose Therapeutics and Skycare Compounding Labs to Provide Patients with a Novel Oral Delivery Option for Pharmaceutical Products

March 7, 2022
RD Therapeutics and Rapid Dose Therapeutics Participate in the CEPI Global Pandemic Preparedness Summit and Support the #100DaysMission — the value of needle-free vaccination, such as the QuickStrip™, will be discussed.

February 10, 2022
Rapid Dose Therapeutics Announces Management Change

January 5, 2022
Rapid Dose Therapeutics Appoints Dr. Michael Glogauer to Advisory Board

December 22, 2021
Rapid Dose Therapeutics and McMaster University’s COVID-19 Vaccine Study Receives NSERC Research and Development Grant

December 15, 2021
Rapid Dose Therapeutics Strengthens Leadership Team with Addition of Rodney Butt & Appoints New Advisory Board Member

December 9, 2021
Rapid Dose Therapeutics Signs Product Supply Agreement with Oakland Health Limited in the United Kingdom

November 30, 2021
Rapid Dose Therapeutics Signs Agreement with AB Strategic Ventures for Business Development Advisory Services with First Nations Enterprises

November 24, 2021
Rapid Dose Therapeutics Completes Milestone One Million QuickStrip™ Units Shipped to a Single Company

1 2 3 4 5 6 7 8 9